ABOUT XONA

Xona Microfluidics’ founders and staff are experts in the field of neuroscience. Their goal is to make available to the research community the same tools and expertise they have developed for their own successful research and to develop innovative systems adapted to new and future needs.

We provide to the neuroscience research community unique, disposable, and high quality platforms. Our platforms provide compartmentalization, fluidic isolation and improved cellular organization over traditionally chaotic neuronal cell cultures.

Xona Microfluidics^® distributes and supports its products directly, as well as through qualified distributors, to hundreds of research organizations in over 20 countries.

Order Now

Dr. Anne Taylor

Chief Scientific Officer & co-founder of Xona Microfluidics, Inc.

Dr. Taylor received her Ph.D. in Biomedical Engineering from the University of California at Irvine, and postdoctoral training at Caltech in Neurobiology. Dr. Taylor was previously faculty at the University of North Carolina at Chapel Hill for 9 years before moving to Xona Microfluidics^® full-time in 2019. Dr. Taylor invented the microfluidic technology used to compartmentalize neurons, together with the scientific co-founders of Xona. Her research has been published in many high-profile publications including Nature Methods, Neuron, and Nature Communications. Read more about Dr. Taylor’s background and publications.

Brad Taylor

C.E.O. & co-founder of Xona Microfluidics, Inc.

Mr. Taylor is a California licensed attorney with over twenty-five years’ experience in corporate transactions, litigation and management. He also worked as a policy consultant for the California Legislature. He has a B.A. in English and political science from U.C.L.A., and a J.D./M.P.A. from Syracuse University.

Dr. Tharkika Nagendran

Senior Scientist at Xona Microfluidics, Inc.

Dr. Nagendran graduated with a Ph.D. in neuroscience from Medical College of Georgia where she studied how calcium signaling influences neuronal development and connectivity in the cerebral cortex. During her postdoctoral training and as a research scientist in the Biomedical Engineering Department at U.N.C., Chapel Hill, she used microfluidic platforms to develop a reliable in vitro injury model to study the molecular mechanisms involved in synaptic remodeling and neuroplasticity following axon damage. Currently at Xona Microfluidics^®, Dr. Nagendran is interested in understanding the biology of neurodegenerative diseases including Alzheimer’s disease and acquired brain injuries like stroke and spinal cord injury. Using human 3D cultures and high throughput microfluidics, Xona is interested in developing therapies for brain injury and neurodegenerative conditions.

Taylor Wilt

Production Manager at Xona Microfluidics, Inc.

Taylor graduated from North Carolina State University with a B.S. in Industrial and Systems Engineering. He has a background in additive manufacturing technologies. Currently, Taylor works on overseeing day to day production and assisting in the development of new products.

Former Members / Consultants:

Joseph Harris – former Chief Operating Officer

Noo Li Jeon, Ph.D. – Scientific Advisor
Other affiliations: Associate Professor, College of Engineering at Seoul National University

Carl Cotman, Ph.D. – Scientific Advisor
Other affiliations: Professor, Neurology School of Medicine, University of California, Irvine
Founding Director, Institute for Brain Aging and Dementia

ABOUT XONA

Dr. Anne Taylor

Brad Taylor

Dr. Tharkika Nagendran

Taylor Wilt

You have Successfully Subscribed!